Additionally, therapy with an adenoviral vector augmenting HO‐1 expression engenders reduced infarct volumes and ameliorated neurological deficits in experimental models of brain ischemia, underscoring its neuroprotective potential.16 This evidence concerns the gene HMOX1 and brain ischemia.